Diffúz nagy B-sejtes limfóma (DLBCL): vizsgálatok itt: Egyesült Államok
133 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleZanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
- Where
- Duarte
- Életkor
- 18 év and over
- People
- 37
- Run by
- City of Hope Medical Center
See details and how to joinNCT06859008 - 1/2. fázisTaking peopleThe OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
- Where
- Canton, Chicago, Dallas, Duarte, Los Angeles, Louisville, Memphis, Omaha, Weeki Wachee, Whittier
- Életkor
- 12 év to 95 év
- People
- 144
- Run by
- AVM Biotechnology Inc
See details and how to joinNCT04329728 - 1/2. fázisTaking peopleAutologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma
- Where
- Valhalla
- Életkor
- 12 év to 70 év
- People
- 20
- Run by
- New York Medical College
See details and how to joinNCT04491370 - 1. fázisTaking peopleSynKIR-310 for Relapsed/Refractory B-NHL
- Where
- Atlanta, Denver, Fairway, New Brunswick, Philadelphia
- Életkor
- 18 év and over
- People
- 36
- Run by
- Verismo Therapeutics
See details and how to joinNCT06544265 - 1. fázisTaking peopleAnti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies
- Where
- Milwaukee
- Életkor
- 18 év and over
- People
- 42
- Run by
- Medical College of Wisconsin
See details and how to joinNCT05544968 - 1. fázisTaking peopleThis is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
- Where
- Austin, TX 78758, Boston, San Antonio
- Életkor
- 18 év and over
- People
- 100
- Run by
- Zumutor Biologics Inc.
See details and how to joinNCT06451497 - 1. fázisTaking peopleA Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
- Where
- Bethesda, Chicago, Cincinnati, Columbus, Dallas, Denver, Duarte, Houston, Miami Beach, Nashville, New York, Orange, Salt Lake City, San Francisco, Sarasota, Seattle
- Életkor
- 18 év and over
- People
- 248
- Run by
- Nurix Therapeutics, Inc.
See details and how to joinNCT04830137 - 1/2. fázisTaking peopleAcalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma
- Where
- Los Angeles, Oklahoma City, Sacramento
- Életkor
- 18 év to 70 év
- People
- 24
- Run by
- Jonsson Comprehensive Cancer Center
See details and how to joinNCT05256641 - 2. fázisTaking peopleA Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma
- Where
- Boston, Miami
- Életkor
- 18 év and over
- People
- 41
- Run by
- Jennifer Crombie, MD
See details and how to joinNCT05800366 - 2. fázisTaking peoplePembro Plus CAR T-cell Therapy in R/R in PMBCL
- Where
- Boston, New York
- Életkor
- 18 év and over
- People
- 35
- Run by
- Jennifer Crombie, MD
See details and how to joinNCT05934448 - 2. fázisTaking peopleFecal Microbiome Transplant to Remodel Intestinal Microbiota for Patients With Relapsed or Refractory Lymphoma With Exposure to High-Risk Antibiotics Who Are Receiving Chimeric Antigen Receptor T Cells
- Where
- Duarte
- Életkor
- 18 év and over
- People
- 56
- Run by
- City of Hope Medical Center
See details and how to joinNCT07042438 - 2. fázisTaking peopleZanubrutinib and Lisocabtagene Maraleucel for the Treatment of Richter's Syndrome
- Where
- Columbus, New York, Salt Lake City
- Életkor
- 18 év and over
- People
- 24
- Run by
- Aseel Alsouqi
See details and how to joinNCT05873712 - 1. fázisTaking peopleTegavivint for Treating Patients With Relapsed or Refractory Large B-Cell Lymphoma
- Where
- Columbus
- Életkor
- 18 év and over
- People
- 18
- Run by
- Lapo Alinari
See details and how to joinNCT05755087 - 1. fázisTaking peopleCC-99282 + Rituximab Early Post CART for Non-Hodgkin's Lymphoma
- Where
- Columbus
- Életkor
- 18 év and over
- People
- 18
- Run by
- Nathan Denlinger
See details and how to joinNCT06209619 - 1/2. fázisTaking peopleCAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies
- Where
- Milwaukee
- Életkor
- 18 év to 80 év
- People
- 100
- Run by
- Medical College of Wisconsin
See details and how to joinNCT04186520 - 1. fázisTaking peopleGenetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem Cell Transplantation for the Treatment of Intermediate or High Grade B-cell Non-Hodgkin Lymphoma
- Where
- Duarte
- Életkor
- 18 év and over
- People
- 15
- Run by
- City of Hope Medical Center
See details and how to joinNCT05432635 - 1. fázisTaking peopleStudy of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
- Where
- Cincinnati, Columbus, Durham, Salt Lake City
- Életkor
- 18 év and over
- People
- 60
- Run by
- Newave Pharmaceutical Inc
See details and how to joinNCT04775745 - 1. fázisTaking peopleStudy of SGR-1505 in Mature B-Cell Neoplasms
- Where
- Boston, Buffalo, Canton, Columbus, Dallas, Durham, Gilbert, Hackensack, Milwaukee, Newark, New York, Pompano Beach, Portland, Providence, Seattle, The Bronx
- Életkor
- 18 év and over
- People
- 98 worldwide
- Run by
- Schrödinger, Inc.
See details and how to joinNCT05544019 · EU 2023-505204-34-00 - 1. fázisTaking peopleB-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells With Fludarabine and Cyclophosphamide Lymphodepletion for the Treatment of Relapsed or Refractory B-cell Hematologic Malignancies
- Where
- Jacksonville
- Életkor
- 18 év and over
- People
- 27
- Run by
- Mayo Clinic
See details and how to joinNCT06191887 - Korai 1. fázisTaking peopleEvaluation of Bridging Radiation Therapy Before CAR T-Cell Infusion for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma
- Where
- Duarte
- Életkor
- 18 év and over
- People
- 9
- Run by
- City of Hope Medical Center
See details and how to joinNCT05800405 - No phaseTaking peoplectDNA-guided Therapy Optimization in Newly Diagnosed DLBCL
- Where
- New York
- Életkor
- 18 év and over
- People
- 40
- Run by
- Hua-Jay J Cherng, MD
See details and how to joinNCT06693830 - 2. fázisTaking peopleZanubrutinib in Patients With DLBCL and MYD88 or NOTCH1 Mutation or CD5+
- Where
- Richmond
- Életkor
- 18 év and over
- People
- 21
- Run by
- Virginia Commonwealth University
See details and how to joinNCT06846463 - 1. fázisBefejeződöttA Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
- Where
- Canton, Columbus, Dallas, Fairfax, Houston, Los Angeles, Pittsburgh, Tamarac
- Életkor
- 18 év and over
- People
- 168 worldwide
- Run by
- OncoNano Medicine, Inc.
See details and how to joinNCT06022029 - 2. fázisTaking peopleA Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Rockville Centre
- Életkor
- 18 év and over
- People
- 50
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06736613 - 2. fázisTaking peopleA Study to Evaluate the Impact of Mosunetuzumab Consolidation for Older Patients With Diffuse Large B-cell Lymphoma (DLBCL) Who Have Detectable Amounts of ctDNA (Circulating Tumor DNA) at the End of Treatment With Pola-R-mini-CHP
- Where
- Rochester
- Életkor
- 70 év and over
- People
- 40
- Run by
- Danielle Wallace
See details and how to joinNCT06828991